125 related articles for article (PubMed ID: 9658492)
1. [Medical treatment of Alzheimer's disease].
López-Pousa S; Serra-Mestres J
Rev Neurol; 1998 Jun; 26(154):1054-60. PubMed ID: 9658492
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease: clinical treatment options.
Reichman WE
Am J Manag Care; 2000 Dec; 6(22 Suppl):S1125-32; discussion S1133-8. PubMed ID: 11142177
[TBL] [Abstract][Full Text] [Related]
3. The treatment of Alzheimer's disease: the approach from a clinical specialist in the trenches.
Hake AM
Semin Neurol; 2002 Mar; 22(1):71-4. PubMed ID: 12170395
[TBL] [Abstract][Full Text] [Related]
4. Psychopharmacology of noncognitive abnormal behaviors in Alzheimer's disease.
Raskind MA
J Clin Psychiatry; 1998; 59 Suppl 9():28-32. PubMed ID: 9720484
[TBL] [Abstract][Full Text] [Related]
5. [Dementing disorders. What benefits do the new anti-dementia drugs have?].
Ihl R
MMW Fortschr Med; 2002 May; Suppl 2():24-6, 28-9. PubMed ID: 12070846
[TBL] [Abstract][Full Text] [Related]
6. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.
Alexopoulos GS; Jeste DV; Chung H; Carpenter D; Ross R; Docherty JP
Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561
[TBL] [Abstract][Full Text] [Related]
7. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic approaches to cognitive deficits in Alzheimer's disease.
Peskind ER
J Clin Psychiatry; 1998; 59 Suppl 9():22-7. PubMed ID: 9720483
[TBL] [Abstract][Full Text] [Related]
9. [Challenging pharmacotherapy in dementia].
Supprian T
MMW Fortschr Med; 2008 May; 150 Suppl 2():33-6. PubMed ID: 18678049
[No Abstract] [Full Text] [Related]
10. Have cholinergic therapies reached their clinical boundary in Alzheimer's disease?
Jones RW
Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S7-S13. PubMed ID: 12973745
[TBL] [Abstract][Full Text] [Related]
11. [Therapy in Alzheimer disease].
Kovács T
Orv Hetil; 2004 Apr; 145(17):925-8. PubMed ID: 15170971
[No Abstract] [Full Text] [Related]
12. Donepezil for Alzheimer's disease.
Benjamin B; Burns A
Expert Rev Neurother; 2007 Oct; 7(10):1243-9. PubMed ID: 17939763
[TBL] [Abstract][Full Text] [Related]
13. Donepezil treatment of severe Alzheimer's disease in nursing home settings. A responder analysis.
Jelic V; Haglund A; Kowalski J; Langworth S; Winblad B
Dement Geriatr Cogn Disord; 2008; 26(5):458-66. PubMed ID: 18984956
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological treatment of Alzheimer's dementia: state of the art and current dilemmas.
Omerovic M; Hampel H; Teipel SJ; Buerger K
World J Biol Psychiatry; 2008; 9(1):69-75. PubMed ID: 17886162
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of Alzheimer's disease].
López OL; Becker JT
Rev Neurol; 2002 Nov 1-15; 35(9):850-9. PubMed ID: 12436384
[TBL] [Abstract][Full Text] [Related]
16. Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease.
Lanari A; Amenta F; Silvestrelli G; Tomassoni D; Parnetti L
Mech Ageing Dev; 2006 Feb; 127(2):158-65. PubMed ID: 16297434
[TBL] [Abstract][Full Text] [Related]
17. [Biological therapies of behavioral and psychological symptoms of dementia: update and prospects].
Gallarda T; Olie JP
Encephale; 2000; 26(3):72-80. PubMed ID: 10951909
[TBL] [Abstract][Full Text] [Related]
18. [From symptomatic to disease modifying therapy? Recent developments in the pharmacotherapy of Alzheimer's disease].
Franke AG; Lieb K; Fellgiebel A
Fortschr Neurol Psychiatr; 2009 Jun; 77(6):326-33. PubMed ID: 19504422
[TBL] [Abstract][Full Text] [Related]
19. Practice guidelines for the diagnosis and treatment of Alzheimer's disease in a managed care setting: Part II--Pharmacologic therapy. Alzheimer's Disease (AD) Managed Care Advisory Council.
Fillit H; Cummings J
Manag Care Interface; 2000 Jan; 13(1):51-6. PubMed ID: 10747691
[TBL] [Abstract][Full Text] [Related]
20. Six and 18-month changes in mild to moderate Alzheimer's patients treated with acetylcholinesterase inhibitors: what can we learn for clinical outcomes of therapeutic trials?
Cortes F; Portet F; Touchon J; Vellas B
J Nutr Health Aging; 2007; 11(4):330-7. PubMed ID: 17653493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
